{"id":1780,"date":"2007-12-03T02:00:00","date_gmt":"2007-12-03T00:00:00","guid":{"rendered":"http:\/\/92.45.35.169\/astrazeneca-basarisini-odullerle-percinliyor\/"},"modified":"2024-08-08T21:10:16","modified_gmt":"2024-08-08T18:10:16","slug":"astrazeneca-basarisini-odullerle-percinliyor","status":"publish","type":"post","link":"https:\/\/www.kariyer.net\/kariyer-rehberi\/astrazeneca-basarisini-odullerle-percinliyor\/","title":{"rendered":"AstraZeneca ba\u015far\u0131s\u0131n\u0131 \u00f6d\u00fcllerle per\u00e7inliyor"},"content":{"rendered":"<div><strong><span style=\"font-weight: normal; font-size: 8.5pt; color: black\"><span style=\"font-size: 11px; font-family: Verdana, Arial, Helvetica, sans-serif\"><\/p>\n<div><strong><span style=\"font-weight: normal; font-size: 8.5pt; color: black\"><img decoding=\"async\" height=\"203\" hspace=\"10\" width=\"160\" align=\"left\" vspace=\"10\" alt=\"\" src=\"http:\/\/web4.kariyer.net\/UploadFiles\/tempPhoto\/kariyerRehberi\/mak394b.jpg\" \/>Kariyer.net&#8217;in \u0130nsana Sayg\u0131 \u00d6d\u00fcl\u00fc&#8217;ne 3. kez lay\u0131k g\u00f6r\u00fclen AstraZeneca, Capital Dergisi&#8217;nin T\u00fcrkiye&#8217;nin En Be\u011fenilen \u015eirketleri Ara\u015ft\u0131rmas\u0131&#8217;nda kendi sekt\u00f6r\u00fcnde 3. s\u0131rada yer ald\u0131. Be\u011fenilen ve tercih edilen firma AstraZeneca&#8217;n\u0131n ba\u015far\u0131s\u0131n\u0131n ard\u0131nda, \u00e7al\u0131\u015fan odakl\u0131 \u0130K y\u00f6netimi yat\u0131yor. &nbsp; <\/span><\/strong><\/div>\n<div><span style=\"font-size: 8.5pt; color: black\">Uluslararas\u0131 alanda faaliyet g\u00f6steren lider firmalardan biri olan AstraZeneca, ba\u015far\u0131s\u0131n\u0131 ald\u0131\u011f\u0131 \u00f6d\u00fcllerle per\u00e7inliyor. AstraZeneca T\u00fcrkiye \u0130nsan Kaynaklar\u0131, \u0130leti\u015fim &amp; Bilgi Hizmetleri Ba\u015fkan Yard\u0131mc\u0131s\u0131 G\u00fcls\u00fcn Y\u00f6r\u00fcko\u011flu K\u00fcvelet &ldquo;AstraZeneca T\u00fcrkiye&#8217;nin 1999 y\u0131l\u0131ndan itibaren ula\u015fm\u0131\u015f oldu\u011fu bu noktada temel ba\u015far\u0131 kriterleri, kurumumuzun i\u015f hedeflerini s\u00fcrekli ve m\u00fckemmel bir bi\u00e7imde ger\u00e7ekle\u015ftirmesi, \u00e7al\u0131\u015fanlar\u0131m\u0131z\u0131n &lsquo;en iyisi olmak&#8217; vizyonuna sahip \u00e7\u0131karak ki\u015fisel performanslar\u0131n\u0131 i\u015f hedeflerine tam kilitli olarak ortaya koymalar\u0131 ve kaynak kullan\u0131m\u0131 konular\u0131nda etkin ve esnek politikalar uygulanmas\u0131 oldu&rdquo; diyor. <\/span><\/div>\n<div><strong><span style=\"font-size: 8.5pt; color: black\"><br \/>Kariyer.net ve Capital&#8217;den ald\u0131\u011f\u0131n\u0131z \u00f6d\u00fcller sizin i\u00e7in ne ifade ediyor?<\/span><\/strong><strong><span style=\"font-size: 8.5pt; color: black\"><\/span><\/strong><span style=\"font-size: 8.5pt; color: black\">Capital dergisinin organize etti\u011fi &#8220;T\u00fcrkiye&#8217;nin En Be\u011fenilen \u015eirketleri Ara\u015ft\u0131rmas\u0131&rdquo;nda farkl\u0131 19 kriter \u00fczerinden de\u011ferlendirmenin yap\u0131ld\u0131\u011f\u0131n\u0131, Kariyer.net&#8217;in \u0130nsana Sayg\u0131 \u00d6d\u00fcl\u00fc&#8217;n\u00fc de y\u00fcksek say\u0131da i\u015f ba\u015fvurusu ve bu ba\u015fvurulara y\u00fczde 99 geri d\u00f6n\u00fc\u015f oran\u0131 ile ald\u0131\u011f\u0131m\u0131z\u0131 s\u00f6yleyebilirim. Her iki \u00f6d\u00fcl de kurumumuz i\u00e7in; i\u015f payda\u015flar\u0131m\u0131z, rakiplerimiz ve i\u015f g\u00fcc\u00fc piyasalar\u0131n\u0131n verdi\u011fi bilgi ve be\u011feni ile olu\u015fmu\u015f son derece gurur verici olaylar. Bu \u00f6d\u00fcller ile be\u011fenilen ve tercih edilen i\u015fveren olma hedefimizde do\u011fru yolda ilerledi\u011fimizi biliyoruz.<\/span><\/div>\n<div><strong><span style=\"font-size: 8.5pt; color: black\"><br \/>\u0130nsana Sayg\u0131 \u00d6d\u00fcl\u00fc alm\u0131\u015f olman\u0131z\u0131n mevcut \u00e7al\u0131\u015fanlar\u0131n\u0131z i\u00e7in etkisi nedir?<\/span><\/strong><strong><span style=\"font-size: 8.5pt; color: black\"><\/span><\/strong><span style=\"font-size: 8.5pt; color: black\">Ben de dahil olmak \u00fczere t\u00fcm AstraZeneca \u00e7al\u0131\u015fanlar\u0131 i\u00e7in bu \u00f6d\u00fcl, kurumumuzun i\u015f stratejisinin ayr\u0131lmaz par\u00e7as\u0131 olan insan stratejimizin, \u00e7al\u0131\u015fan odakl\u0131l\u0131\u011f\u0131m\u0131z\u0131n sadece i\u00e7eride \u00e7al\u0131\u015fanlar i\u00e7in de\u011fil ayn\u0131 zamanda potansiyel \u00e7al\u0131\u015fanlar i\u00e7in de sergilendi\u011finin ifadesi. Bu da bizim kurum ba\u011fl\u0131l\u0131\u011f\u0131m\u0131z\u0131 daha da \u00fcst d\u00fczeye \u00e7\u0131kar\u0131yor.<\/span><\/div>\n<div><strong><span style=\"font-size: 8.5pt; color: black\"><br \/>\u0130la\u00e7 sekt\u00f6r\u00fc insan kayna\u011f\u0131n\u0131n \u00e7ok \u00f6nemli oldu\u011fu sekt\u00f6rlerden biri. \u0130nsan kayna\u011f\u0131 AstraZeneca&#8217;da nas\u0131l de\u011ferlendiriliyor?<\/span><\/strong><strong><span style=\"font-size: 8.5pt; color: black\"><\/span><\/strong><span style=\"font-size: 8.5pt; color: black\">Kurumumuzun vizyonu ve misyonu itibar\u0131 ile s\u00f6ylemi ve hedefi &ldquo;En iyisi olmak&rdquo;. Buna paralel olarak olu\u015fturdu\u011fumuz AZ \u0130K stratejisinde de oda\u011f\u0131m\u0131z, do\u011fru yetkinlikler ile donanm\u0131\u015f do\u011fru liderlerin, do\u011fru rollerde do\u011fru zamanlama ile bulunuyor olmas\u0131. Bu, kurumumuzun bug\u00fcnk\u00fc performans\u0131n\u0131 optimize etmeye ve bunun yan\u0131nda organizasyonumuzun gelece\u011fe y\u00f6nelik zorluklar\u0131 kar\u015f\u0131lama kabiliyetlerini art\u0131rmaya ve h\u0131zland\u0131rmaya y\u00f6nelik bir strateji. Bu stratejinin de en kilit unsuru olan Yetenek Y\u00f6netimi&#8217;ni dikkatle ele al\u0131yoruz. Kapsaml\u0131 olarak 2001 y\u0131l\u0131ndan beri s\u00fcrd\u00fcr\u00fclen yetenek y\u00f6netimi ve yetenek havuzu uygulamas\u0131 bug\u00fcn hem global olarak AstraZeneca&#8217;n\u0131n bu konuya verdi\u011fi \u00f6nemi g\u00f6steriyor. Hem de AstraZeneca&#8217;n\u0131n T\u00fcrkiye&#8217;deki de\u011fi\u015fim ihtiya\u00e7lar\u0131 paralelinde stratejik kararlar\u0131n al\u0131nabilmesini kolayla\u015ft\u0131rarak ve h\u0131zland\u0131rarak de\u011fi\u015fime destek oluyor.<\/span><\/div>\n<div><strong><span style=\"font-size: 8.5pt; color: black\"><br \/>Ar-Ge \u00e7al\u0131\u015fmalar\u0131 i\u00e7in y\u0131lda 12 bin ki\u015fi istihdam ediyorsunuz. Bunun verimlili\u011fe geri d\u00f6n\u00fc\u015f\u00fc nas\u0131l oluyor?<\/span><\/strong><strong><span style=\"font-size: 8.5pt; color: black\"><\/span><\/strong><span style=\"font-size: 8.5pt; color: black\">\u0130la\u00e7 sekt\u00f6r\u00fcnde uluslararas\u0131 faaliyet g\u00f6steren lider firmalardan biriyiz. 100&#8217;\u00fcn \u00fczerinde \u00fclkede faaliyetimiz ve 64 binin \u00fczerinde de \u00e7al\u0131\u015fan\u0131m\u0131z var. Bunun 12 bini Ar-Ge&#8217;de hizmet veriyor. AstraZeneca olarak Ar-Ge taban\u0131n\u0131n g\u00fcc\u00fc, sa\u011fl\u0131k alan\u0131nda g\u00fc\u00e7l\u00fc ila\u00e7 portf\u00f6y\u00fc ile pek \u00e7ok tedavi alan\u0131nda insanl\u0131\u011fa hizmet vermeyi s\u00fcrd\u00fcr\u00fclebilir hale getiriyor.<\/span><\/div>\n<div><strong><span style=\"font-size: 8.5pt; color: black\"><br \/>\u0130K vizyonunuzdan bahseder misiniz?<\/span><\/strong><strong><span style=\"font-size: 8.5pt; color: black\"><\/span><\/strong><span style=\"font-size: 8.5pt; color: black\">\u0130K vizyonumuz, AZ de\u011ferlerine ba\u011fl\u0131 olarak performans k\u00fclt\u00fcr\u00fcn\u00fc ve liderli\u011fi geli\u015ftirmek yolu ile &ldquo;En iyisi olmak&rdquo; hedefimize ula\u015fmak. Bunun i\u00e7in t\u00fcm \u00e7al\u0131\u015fanlar\u0131m\u0131z\u0131 performansa y\u00f6nelik, m\u00fc\u015fteri odakl\u0131 ve kazanma azmi i\u00e7inde \u00e7al\u0131\u015fan tak\u0131mlar halinde, geli\u015fiminin s\u00fcrekli oldu\u011fu bir ortamda destekleme \u00e7abas\u0131 i\u00e7indeyiz.<\/span><\/div>\n<div><strong><span style=\"font-size: 8.5pt; color: black\"><br \/>2005 y\u0131l\u0131 sonunda \u0130K olarak yeniden yap\u0131lanman\u0131z\u0131n amac\u0131 neydi, koydu\u011funuz hedeflerin neresindesiniz?<\/span><\/strong><strong><span style=\"font-size: 8.5pt; color: black\"><\/span><\/strong><span style=\"font-size: 8.5pt; color: black\">\u0130K olarak, i\u015fimiz ve kadrolar\u0131m\u0131zdaki b\u00fcy\u00fcmeye paralel olarak yeniden yap\u0131lanmaya gittik. Bunu yaparken, d\u00fcnyada yap\u0131lanmalar\u0131n\u0131 tamamlam\u0131\u015f iyi i\u015fleyen \u0130K yap\u0131lar\u0131n\u0131 inceledik ve \u0130K&#8217;dan beklentileri ele ald\u0131k. \u0130K&#8217;n\u0131n rol\u00fc temel \u0130K i\u015flevlerinin yan\u0131nda i\u015fimizin gerektirdi\u011fi de\u011fi\u015fimleri s\u00fcratle desteklemek ve ileti\u015fimi g\u00fc\u00e7lendirmek y\u00f6n\u00fcnde odakland\u0131\u011f\u0131 i\u00e7in yeni yap\u0131m\u0131zda bu alanlar\u0131 g\u00fc\u00e7lendiren bir altyap\u0131 olu\u015fturmaya \u00e7al\u0131\u015ft\u0131k. \u015eu anda, t\u00fcm firma b\u00fct\u00fcn\u00fcnde bu anlay\u0131\u015f ile y\u00fcr\u00fctt\u00fc\u011f\u00fcm\u00fcz yerel projelerimiz var. Biz \u0130K olarak AstraZeneca&#8217;daki t\u00fcm operasyonlar\u0131n, fonksiyonlar\u0131n yan\u0131nda kendimizi bir i\u015f orta\u011f\u0131 olarak konumland\u0131rabiliyoruz. Firma taraf\u0131nda y\u00fcr\u00fcyen projelerin pek \u00e7o\u011funda ya lider ya da tak\u0131mda\u015f olarak yer al\u0131yoruz.<\/span><\/div>\n<div><strong><span style=\"font-size: 8.5pt; color: black\"><br \/>Online HR uygulamalar\u0131 (e-HR) \u0130nsan Kaynaklar\u0131 departman\u0131n\u0131z\u0131n verimini nas\u0131l etkiliyor?<\/span><\/strong><strong><span style=\"font-size: 8.5pt; color: black\"><\/span><\/strong><span style=\"font-size: 8.5pt; color: black\">AstraZeneca olarak sekt\u00f6r\u00fcm\u00fczde e-HR uygulamalar\u0131na en erken ba\u015flayanlardan biriyiz. \u0130yi bir veritaban\u0131 olu\u015fturma yolu ile do\u011fru kaynaklara en k\u0131sa zamanda ula\u015fmak, h\u0131zl\u0131, esnek ve kaliteli s\u00fcre\u00e7 y\u00f6netimi, devaml\u0131 \/ g\u00fcncel yenilenme ve gelece\u011fe y\u00f6nelik planlaman\u0131n kolayla\u015fmas\u0131, verimli \u00e7al\u0131\u015fmay\u0131 te\u015fvik ve her an yeni bir duruma haz\u0131rl\u0131kl\u0131 olman\u0131z\u0131 m\u00fcmk\u00fcn k\u0131l\u0131yor. <\/span><\/div>\n<div><strong><span style=\"font-size: 8.5pt; color: black\"><br \/>\u00c7al\u0131\u015fan memnuniyeti, motivasyon, performans de\u011ferlendirme gibi \u00e7al\u0131\u015fmalar\u0131n\u0131zdan k\u0131saca bahseder misiniz?<\/span><\/strong><strong><span style=\"font-size: 8.5pt; color: black\"><\/span><\/strong><span style=\"font-size: 8.5pt; color: black\">AstraZeneca Global olarak ve AstraZeneca T\u00fcrkiye olarak s\u00fcrekli ve a\u00e7\u0131k ileti\u015fimin destekleyicisi olan \u00e7al\u0131\u015fan memnuniyeti \u00e7al\u0131\u015fmalar\u0131n\u0131 \/ ara\u015ft\u0131rmalar\u0131n\u0131 s\u0131kl\u0131kla yap\u0131yoruz.&nbsp;<\/span><span style=\"font-size: 8.5pt; color: black\">\u0130\u015f ba\u015far\u0131lar\u0131m\u0131za ba\u011fl\u0131 olarak ortaya konulan \u00f6d\u00fcllendirme planlar\u0131, hedeflere y\u00f6nelik olarak yapt\u0131\u011f\u0131m\u0131z performans de\u011ferlendirme uygulamalar\u0131, \u00fcst\u00fcn performans ile birle\u015fen liderlik davran\u0131\u015flar\u0131n\u0131n s\u00fcrekli bi\u00e7imde de\u011ferlendiriliyor olmas\u0131 ile \u00e7al\u0131\u015fanlar\u0131m\u0131za kariyer geli\u015fimi anlam\u0131nda da f\u0131rsat alanlar\u0131 sunuyoruz.<\/span><\/div>\n<div style=\"margin: 0cm 0cm 10pt\">&nbsp;<\/div>\n<div style=\"margin: 0cm 0cm 10pt\">&nbsp;<\/div>\n<p><\/span><\/span><\/strong><\/div>\n<!-- templates\/buttons-placeholder.php -->\n<div class=\"da-reactions-outer TpostID1780\">\n\t    <div class=\"da-reactions-data da-reactions-container-async center\"\n         data-type=\"post\"\n         data-id=\"1780\"\n         id=\"da-reactions-slot-post-1780\">\n        <div class=\"da-reactions-static\">\n\t\t\t<img src=\"https:\/\/www.kariyer.net\/kariyer-rehberi\/wp-content\/plugins\/da-reactions\/assets\/dist\/loading.svg\" alt=\"Loading spinner\" width=\"48\" height=\"48\" style=\"width:48px\" \/>\n        <\/div>\n    <\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Kariyer.net&#8217;in \u0130nsana Sayg\u0131 \u00d6d\u00fcl\u00fc&#8217;ne 3. kez lay\u0131k g\u00f6r\u00fclen AstraZeneca, Capital Dergisi&#8217;nin T\u00fcrkiye&#8217;nin En Be\u011fenilen \u015eirketleri Ara\u015ft\u0131rmas\u0131&#8217;nda kendi sekt\u00f6r\u00fcnde 3. s\u0131rada yer ald\u0131. Be\u011fenilen ve tercih edilen firma AstraZeneca&#8217;n\u0131n ba\u015far\u0131s\u0131n\u0131n ard\u0131nda, \u00e7al\u0131\u015fan odakl\u0131 \u0130K y\u00f6netimi yat\u0131yor. &nbsp; Uluslararas\u0131 alanda faaliyet g\u00f6steren lider firmalardan biri olan AstraZeneca, ba\u015far\u0131s\u0131n\u0131 ald\u0131\u011f\u0131 \u00f6d\u00fcllerle per\u00e7inliyor. AstraZeneca T\u00fcrkiye \u0130nsan Kaynaklar\u0131, \u0130leti\u015fim &amp; [&hellip;]<\/p>\n<!-- templates\/buttons-placeholder.php -->\n<div class=\"da-reactions-outer TpostID1780\">\n\t    <div class=\"da-reactions-data da-reactions-container-async center\"\n         data-type=\"post\"\n         data-id=\"1780\"\n         id=\"da-reactions-slot-post-1780\">\n        <div class=\"da-reactions-static\">\n\t\t\t<img src=\"https:\/\/www.kariyer.net\/kariyer-rehberi\/wp-content\/plugins\/da-reactions\/assets\/dist\/loading.svg\" alt=\"Loading spinner\" width=\"48\" height=\"48\" style=\"width:48px\" \/>\n        <\/div>\n    <\/div>\n<\/div>\n","protected":false},"author":8,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_elementor_edit_mode":"","_elementor_template_type":"","_elementor_data":"","_elementor_page_settings":null,"_elementor_conditions":[]},"categories":[46,2214],"tags":[],"class_list":{"0":"post-1780","1":"post","2":"type-post","3":"status-publish","4":"format-standard","6":"category-is-hayati","7":"category-yasam"},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v21.4 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>AstraZeneca ba\u015far\u0131s\u0131n\u0131 \u00f6d\u00fcllerle per\u00e7inliyor | Kariyer Rehberi<\/title>\n<meta name=\"description\" content=\"Kariyer.net&#039;in \u0130nsana Sayg\u0131 \u00d6d\u00fcl\u00fc&#039;ne 3. kez lay\u0131k g\u00f6r\u00fclen AstraZeneca, Capital Dergisi&#039;nin T\u00fcrkiye&#039;nin En Be\u011fenilen \u015eirketleri Ara\u015ft\u0131rmas\u0131&#039;nda kendi\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.kariyer.net\/kariyer-rehberi\/astrazeneca-basarisini-odullerle-percinliyor\/\" \/>\n<meta property=\"og:locale\" content=\"tr_TR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"AstraZeneca ba\u015far\u0131s\u0131n\u0131 \u00f6d\u00fcllerle per\u00e7inliyor\" \/>\n<meta property=\"og:description\" content=\"Kariyer.net&#039;in \u0130nsana Sayg\u0131 \u00d6d\u00fcl\u00fc&#039;ne 3. kez lay\u0131k g\u00f6r\u00fclen AstraZeneca, Capital Dergisi&#039;nin T\u00fcrkiye&#039;nin En Be\u011fenilen \u015eirketleri Ara\u015ft\u0131rmas\u0131&#039;nda kendi\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.kariyer.net\/kariyer-rehberi\/astrazeneca-basarisini-odullerle-percinliyor\/\" \/>\n<meta property=\"og:site_name\" content=\"Kariyer Rehberi\" \/>\n<meta property=\"article:published_time\" content=\"2007-12-03T00:00:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-08-08T18:10:16+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/web4.kariyer.net\/UploadFiles\/tempPhoto\/kariyerRehberi\/mak394b.jpg\" \/>\n<meta name=\"author\" content=\"Kariyer.net\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Yazan:\" \/>\n\t<meta name=\"twitter:data1\" content=\"Kariyer.net\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tahmini okuma s\u00fcresi\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 dakika\" \/>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"AstraZeneca ba\u015far\u0131s\u0131n\u0131 \u00f6d\u00fcllerle per\u00e7inliyor | Kariyer Rehberi","description":"Kariyer.net'in \u0130nsana Sayg\u0131 \u00d6d\u00fcl\u00fc'ne 3. kez lay\u0131k g\u00f6r\u00fclen AstraZeneca, Capital Dergisi'nin T\u00fcrkiye'nin En Be\u011fenilen \u015eirketleri Ara\u015ft\u0131rmas\u0131'nda kendi","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.kariyer.net\/kariyer-rehberi\/astrazeneca-basarisini-odullerle-percinliyor\/","og_locale":"tr_TR","og_type":"article","og_title":"AstraZeneca ba\u015far\u0131s\u0131n\u0131 \u00f6d\u00fcllerle per\u00e7inliyor","og_description":"Kariyer.net'in \u0130nsana Sayg\u0131 \u00d6d\u00fcl\u00fc'ne 3. kez lay\u0131k g\u00f6r\u00fclen AstraZeneca, Capital Dergisi'nin T\u00fcrkiye'nin En Be\u011fenilen \u015eirketleri Ara\u015ft\u0131rmas\u0131'nda kendi","og_url":"https:\/\/www.kariyer.net\/kariyer-rehberi\/astrazeneca-basarisini-odullerle-percinliyor\/","og_site_name":"Kariyer Rehberi","article_published_time":"2007-12-03T00:00:00+00:00","article_modified_time":"2024-08-08T18:10:16+00:00","og_image":[{"url":"http:\/\/web4.kariyer.net\/UploadFiles\/tempPhoto\/kariyerRehberi\/mak394b.jpg","type":"","width":"","height":""}],"author":"Kariyer.net","twitter_card":"summary_large_image","twitter_misc":{"Yazan:":"Kariyer.net","Tahmini okuma s\u00fcresi":"5 dakika"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.kariyer.net\/kariyer-rehberi\/astrazeneca-basarisini-odullerle-percinliyor\/#article","isPartOf":{"@id":"https:\/\/www.kariyer.net\/kariyer-rehberi\/astrazeneca-basarisini-odullerle-percinliyor\/"},"author":{"name":"Kariyer.net","@id":"https:\/\/www.kariyer.net\/kariyer-rehberi\/#\/schema\/person\/eb36201afd42c03bc83b82060447b2c9"},"headline":"AstraZeneca ba\u015far\u0131s\u0131n\u0131 \u00f6d\u00fcllerle per\u00e7inliyor","datePublished":"2007-12-03T00:00:00+00:00","dateModified":"2024-08-08T18:10:16+00:00","mainEntityOfPage":{"@id":"https:\/\/www.kariyer.net\/kariyer-rehberi\/astrazeneca-basarisini-odullerle-percinliyor\/"},"wordCount":1084,"commentCount":0,"publisher":{"@id":"https:\/\/www.kariyer.net\/kariyer-rehberi\/#organization"},"image":{"@id":"https:\/\/www.kariyer.net\/kariyer-rehberi\/astrazeneca-basarisini-odullerle-percinliyor\/#primaryimage"},"thumbnailUrl":"http:\/\/web4.kariyer.net\/UploadFiles\/tempPhoto\/kariyerRehberi\/mak394b.jpg","articleSection":["\u0130\u015f Hayat\u0131","Ya\u015fam"],"inLanguage":"tr","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.kariyer.net\/kariyer-rehberi\/astrazeneca-basarisini-odullerle-percinliyor\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.kariyer.net\/kariyer-rehberi\/astrazeneca-basarisini-odullerle-percinliyor\/","url":"https:\/\/www.kariyer.net\/kariyer-rehberi\/astrazeneca-basarisini-odullerle-percinliyor\/","name":"AstraZeneca ba\u015far\u0131s\u0131n\u0131 \u00f6d\u00fcllerle per\u00e7inliyor | Kariyer Rehberi","isPartOf":{"@id":"https:\/\/www.kariyer.net\/kariyer-rehberi\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.kariyer.net\/kariyer-rehberi\/astrazeneca-basarisini-odullerle-percinliyor\/#primaryimage"},"image":{"@id":"https:\/\/www.kariyer.net\/kariyer-rehberi\/astrazeneca-basarisini-odullerle-percinliyor\/#primaryimage"},"thumbnailUrl":"http:\/\/web4.kariyer.net\/UploadFiles\/tempPhoto\/kariyerRehberi\/mak394b.jpg","datePublished":"2007-12-03T00:00:00+00:00","dateModified":"2024-08-08T18:10:16+00:00","description":"Kariyer.net'in \u0130nsana Sayg\u0131 \u00d6d\u00fcl\u00fc'ne 3. kez lay\u0131k g\u00f6r\u00fclen AstraZeneca, Capital Dergisi'nin T\u00fcrkiye'nin En Be\u011fenilen \u015eirketleri Ara\u015ft\u0131rmas\u0131'nda kendi","breadcrumb":{"@id":"https:\/\/www.kariyer.net\/kariyer-rehberi\/astrazeneca-basarisini-odullerle-percinliyor\/#breadcrumb"},"inLanguage":"tr","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.kariyer.net\/kariyer-rehberi\/astrazeneca-basarisini-odullerle-percinliyor\/"]}]},{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/www.kariyer.net\/kariyer-rehberi\/astrazeneca-basarisini-odullerle-percinliyor\/#primaryimage","url":"http:\/\/web4.kariyer.net\/UploadFiles\/tempPhoto\/kariyerRehberi\/mak394b.jpg","contentUrl":"http:\/\/web4.kariyer.net\/UploadFiles\/tempPhoto\/kariyerRehberi\/mak394b.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.kariyer.net\/kariyer-rehberi\/astrazeneca-basarisini-odullerle-percinliyor\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Anasayfa","item":"https:\/\/www.kariyer.net\/kariyer-rehberi\/"},{"@type":"ListItem","position":2,"name":"AstraZeneca ba\u015far\u0131s\u0131n\u0131 \u00f6d\u00fcllerle per\u00e7inliyor"}]},{"@type":"WebSite","@id":"https:\/\/www.kariyer.net\/kariyer-rehberi\/#website","url":"https:\/\/www.kariyer.net\/kariyer-rehberi\/","name":"Kariyer Rehberi","description":"\u0130\u015f D\u00fcnyas\u0131yla \u0130lgili Bilmek \u0130stedi\u011finiz Her \u015eey","publisher":{"@id":"https:\/\/www.kariyer.net\/kariyer-rehberi\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.kariyer.net\/kariyer-rehberi\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"tr"},{"@type":"Organization","@id":"https:\/\/www.kariyer.net\/kariyer-rehberi\/#organization","name":"Kariyer.net","url":"https:\/\/www.kariyer.net\/kariyer-rehberi\/","logo":{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/www.kariyer.net\/kariyer-rehberi\/#\/schema\/logo\/image\/","url":"https:\/\/www.kariyer.net\/kariyer-rehberi-new\/wp-content\/uploads\/2023\/01\/og-image11.jpg","contentUrl":"https:\/\/www.kariyer.net\/kariyer-rehberi-new\/wp-content\/uploads\/2023\/01\/og-image11.jpg","width":800,"height":800,"caption":"Kariyer.net"},"image":{"@id":"https:\/\/www.kariyer.net\/kariyer-rehberi\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.kariyer.net\/kariyer-rehberi\/#\/schema\/person\/eb36201afd42c03bc83b82060447b2c9","name":"Kariyer.net","image":{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/secure.gravatar.com\/avatar\/ddce3ac68cb52fb2ae004bcee334e49ccc6361fefd68c5f6f4d2a86630c28b2e?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/ddce3ac68cb52fb2ae004bcee334e49ccc6361fefd68c5f6f4d2a86630c28b2e?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/ddce3ac68cb52fb2ae004bcee334e49ccc6361fefd68c5f6f4d2a86630c28b2e?s=96&d=mm&r=g","caption":"Kariyer.net"},"url":"https:\/\/www.kariyer.net\/kariyer-rehberi\/author\/kariyer-net\/"}]}},"_links":{"self":[{"href":"https:\/\/www.kariyer.net\/kariyer-rehberi\/wp-json\/wp\/v2\/posts\/1780","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.kariyer.net\/kariyer-rehberi\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.kariyer.net\/kariyer-rehberi\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.kariyer.net\/kariyer-rehberi\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/www.kariyer.net\/kariyer-rehberi\/wp-json\/wp\/v2\/comments?post=1780"}],"version-history":[{"count":1,"href":"https:\/\/www.kariyer.net\/kariyer-rehberi\/wp-json\/wp\/v2\/posts\/1780\/revisions"}],"predecessor-version":[{"id":20706,"href":"https:\/\/www.kariyer.net\/kariyer-rehberi\/wp-json\/wp\/v2\/posts\/1780\/revisions\/20706"}],"wp:attachment":[{"href":"https:\/\/www.kariyer.net\/kariyer-rehberi\/wp-json\/wp\/v2\/media?parent=1780"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.kariyer.net\/kariyer-rehberi\/wp-json\/wp\/v2\/categories?post=1780"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.kariyer.net\/kariyer-rehberi\/wp-json\/wp\/v2\/tags?post=1780"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}